One mechanism by which macrophages can function in vivo to restrict neoplastic growth is direct cytolysis of tumor cells. Although tumor cell cytolysis by activated macrophages displays many characteristics of classic receptor/ligand interactions, the tumor cell surface moieties recognized by macrophages have not been identified. Previous studies in this laboratory have found that sensitivity to cytolysis by macrophages is not an obligate outcome of cellular transformation. Furthermore, among cultured cell lines, transformed by the same oncogenic virus and from the same strain of mice, resistance to macrophage cytolysis in vitro is predictive of progressive tumor growth in vivo. Specific goals of this application are to: (1) determine whether H-2-linked genes or endogenous retroviral genes function to control the macrophage-resistant phenotype of transformed cells; (2) determine, at a molecular level, the mechanisms by which resistance to macrophage cytolysis occurs in different transformed cells; (3) assess the importance of the macrophage-resistant phenotype in the development of progressing tumors in vivo; and (4) identify the tumor cell surface ligands recognized by cytolytic macrophages. The overall goal of these studies is to learn, from an immunologist's point of view, which genotypic and phenotypic changes occur that allow the cell to escape normal homeostatic mechanisms during the development of a neoplastic cell. (IB)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA040266-01
Application #
3180009
Study Section
Experimental Immunology Study Section (EI)
Project Start
1985-07-01
Project End
1990-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Duerksen-Hughes, P J; Day, D B; Laster, S M et al. (1992) Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40-transformed cells by activated macrophages. J Immunol 149:2114-22
Perez, C; Albert, I; DeFay, K et al. (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63:251-8
Laster, S M; Gooding, L R (1990) Evidence that a target-derived soluble factor is necessary for the selective lysis of SV40-transformed fibroblasts by activated mouse macrophages. J Immunol 144:1438-43
Gooding, L R; Sofola, I O; Tollefson, A E et al. (1990) The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J Immunol 145:3080-6
Dhingra, K; Gooding, L R; Gordon, D S (1989) Oncogene expression and cytotoxic activity of tumor necrosis factor against human cancer cells. J Biol Response Mod 8:337-43
Scanlon, M; Laster, S M; Wood, J G et al. (1989) Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments. Proc Natl Acad Sci U S A 86:182-6
Gooding, L R; Taylor, J R; Laster, S M et al. (1989) Evidence against expression of an endogenous murine leukemia virus causing cellular resistance to lysis by activated macrophages. J Immunol 142:257-62
Duerksen-Hughes, P; Wold, W S; Gooding, L R (1989) Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J Immunol 143:4193-200
Gooding, L R; Elmore, L W; Tollefson, A E et al. (1988) A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341-6
Laster, S M; Wood, J G; Gooding, L R (1988) Target-induced changes in macrophage migration may explain differences in lytic sensitivity among simian virus 40-transformed fibroblasts. J Immunol 141:221-7

Showing the most recent 10 out of 13 publications